Evaluation of non-uniform weighting in non-linear regression for pharmacokinetic neuroreceptor modelling

Nuclear Medicine Communications

Volumn 29, Issue 2, 2008, Pages 179-188

  Thiele, Frank ^a   Buchert, Ralph ^b  

^a PHILIPS RESEARCH LABORATORIES   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Kinetic modelling; Positron emission tomography (PET); Simplified reference tissue model; Weighted non linear regression

Indexed keywords

ARTICLE; COMPUTER SIMULATION; LIGAND BINDING; MATHEMATICAL MODEL; NONLINEAR REGRESSION ANALYSIS; PARAMETER; POISSON DISTRIBUTION; POSITRON EMISSION TOMOGRAPHY; RECEPTOR AFFINITY;

ANILINE COMPOUNDS; HUMANS; ISOQUINOLINES; KINETICS; LIGANDS; LINEAR MODELS; MODELS, NEUROLOGICAL; NEURONS; POISSON DISTRIBUTION; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RADIOPHARMACEUTICALS; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SULFIDES;

EID: 37349076920     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f28138     Document Type: Article

References (30)

1. Amisaki T, Eguchi S. A comparison of methods for estimating individual pharmacokinetic parameters. J Pharmacokinet Biopharm 1999; 27:103-121.
2. Muzic RF, Christian BT. Evaluation of objective functions for estimation of kinetic parameters. Med Phys 2006; 33:342-353.
3. Peck CC, Beal SL, Sheiner LB, Nichols AI. Extended least squares nonlinear regression: a possible solution to the ‘choice of weights’ problem in analysis of individual pharmacokinetic data. J Pharmacokinet Biopharm 1984; 12:545-558.
4. van Houwelingen JC. Use and abuse of variance models in regression. Biometrics 1988; 44:1073-1081.
5. Yaqub M, Boellaard R, Kropholler MA, Lammertsma AA. Optimization algorithms and weighting factors for analysis of dynamic PET studies. Phys Med Biol 2006; 51:4217-4232.
6. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage 1996; 4:153-158.
7. 11C](+)McN5652. Synapse 1995; 20:37-43.
8. 11C]DASB. Eur J Nucl Med 2000; 27:1719-1722.
9. 11C]raclopride binding to D2-dopamine receptors studied by PET - a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 1989; 9:696-708.
10. 11C]McN 5652. J Nucl Med 2000; 41:1465-1477.
11. Buchert R, Varga J, Mester J. Limitations of bi-linear regression analysis for the determination of receptor occupancy with positron emission tomography. Nucl Med Commun 2004; 25:451-459.
12. Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab 2001; 21:1342-1353.
13. 11C](+)McN5652: assessment of methods. J Cereb Blood Flow Metab 2000; 20:253-262.
14. 11C]raclopride studies. J Cereb Blood Flow Metab 1996; 16:42-52.
15. Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, et al. Long-term effects of ‘ecstasy’ use on serotonin transporters of the brain investigated by PET. J Nucl Med 2003; 44:375-384.
16. Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, et al. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 2001; 158:1843-1849.
17. Reimold M, Mueller-Schauenburg W, Becker GA, Reischl G, Dohmen BM, Bares R. Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves. Eur J Nucl Med Mol Imaging 2004; 31:564-577.
18. Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab 2001; 21:307-320.
19. Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 2001; 28:595-608.
20. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C. 2nd edn. Cambridge: Cambridge University Press; 2002.
21. Motulsky HJ, Ransnas LA. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J 1987; 1:365-374.
22. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003; 23:1096-1112.
23. Wager TD, Keller MC, Lacey SC, Jonides J. Increased sensitivity in neuroimaging analyses using robust regression. NeuroImage 2005; 26:99-113.
24. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. NeuroImage 1998; 8:426-440.
25. Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 2002; 22:1440-1452.
26. Hwang DR, Narendran R, Huang Y, Slifstein M, Talbot PS, Sudo Y, et al. Quantitative analysis of (−)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates. J Nucl Med 2004; 45:338-346.
27. Burger C, Buck A. Requirements and implementation of a flexible kinetic modelling tool. J Nucl Med 1997; 38:1818-1823.
28. Thiele F, Mollus S, Bal M, Fischer A, Paulus T, Spies L, et al. Investigation of ecstasy-induced changes of serotonin transporter availability: Statistical power of nonlinear vs linear regression. In: SNM 52nd Annual Meeting; 2005.
29. 11C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. Nucl Med Biol 2000; 27:487-492.
30. Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab 2001; 21:635-652.